Advaxis to Present at the BIO CEO & Investor Conference
February 03, 2014 07:30 ET
|
Advaxis
PRINCETON, N.J., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, announced that Daniel J. O'Connor,...